Drug Shortage Report for CEFEPIME FOR INJECTION

Last updated on 2017-10-05 History
Report ID 698
Drug Identification Number 02319039
Brand name CEFEPIME FOR INJECTION
Common or Proper name CEFEPIME
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) CEFEPIME (CEFEPIME HYDROCHLORIDE)
Strength(s) 2G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INJECTION
Packaging size 20 ML
ATC code J01DE
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2012-08-23
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2017-10-05
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2017-03-12 French Compare
v1 2017-03-12 English Compare